{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Clofarabine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Clofarabine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Clofarabine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "clofarabine",
    "trial_2_text": "Clofarabine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Clofarabine Supplement: 60 participants will take Clofarabine 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Clofarabine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Clofarabine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.2718453109264374,
      "123": 0.22823187708854675,
      "68": 0.21703080832958221,
      "49": 0.20087939500808716,
      "177": 0.19001232087612152,
      "20": 0.15759731829166412,
      "173": 0.14548709988594055,
      "17": 0.14456668496131897,
      "9": 0.13350091874599457,
      "2": 0.13099779188632965,
      "37": 0.12950089573860168,
      "21": 0.12770411372184753,
      "189": 0.12567491829395294,
      "14": 0.11807842552661896,
      "77": 0.11389642208814621,
      "64": 0.11034133285284042,
      "46": 0.1103304997086525,
      "126": 0.10884558409452438,
      "228": 0.10099726915359497,
      "170": 0.09807759523391724,
      "114": 0.0967470332980156,
      "180": 0.09275546669960022,
      "76": 0.09180108457803726,
      "78": 0.09176316112279892,
      "67": 0.09068544209003448,
      "188": 0.08907242119312286,
      "101": 0.08794019371271133,
      "179": 0.08090319484472275,
      "350": 0.08047295361757278,
      "29": 0.0781339555978775,
      "194": 0.07758461683988571,
      "249": 0.0707063227891922,
      "144": 0.06981232762336731,
      "142": 0.06809403002262115,
      "61": 0.0676407665014267,
      "1": 0.06752006709575653,
      "27": 0.06512213498353958,
      "72": 0.0646979957818985,
      "35": 0.06454018503427505,
      "200": 0.06348308175802231,
      "30": 0.06330069899559021,
      "191": 0.05911820009350777,
      "96": 0.05865484103560448,
      "79": 0.05849825218319893,
      "269": 0.055773552507162094,
      "396": 0.0556010864675045,
      "147": 0.055376723408699036,
      "288": 0.054293207824230194,
      "82": 0.05287550389766693,
      "239": 0.05195028707385063,
      "261": 0.05123812332749367,
      "282": 0.05109192430973053,
      "5": 0.050557445734739304,
      "102": 0.050263166427612305,
      "243": 0.050208017230033875,
      "361": 0.049935147166252136,
      "193": 0.04978795349597931,
      "85": 0.04974762350320816,
      "441": 0.0497259758412838,
      "104": 0.04938671737909317,
      "253": 0.04879540577530861,
      "131": 0.048420269042253494,
      "151": 0.04732628911733627,
      "122": 0.04639523848891258,
      "211": 0.0462583564221859,
      "121": 0.045568738132715225,
      "38": 0.045035600662231445,
      "212": 0.04486526921391487,
      "86": 0.04134560003876686,
      "18": 0.041012924164533615,
      "69": 0.04052552208304405,
      "455": 0.040012259036302567,
      "130": 0.039924271404743195,
      "28": 0.03808409720659256,
      "186": 0.036559849977493286,
      "286": 0.0363871231675148,
      "355": 0.03584742918610573,
      "347": 0.03410690650343895,
      "133": 0.03388954699039459,
      "221": 0.0336710661649704,
      "100": 0.033637646585702896,
      "154": 0.03316114470362663,
      "234": 0.03257541358470917,
      "356": 0.0321459099650383,
      "466": 0.03201190382242203,
      "89": 0.03165391460061073,
      "276": 0.03159753978252411,
      "268": 0.031433410942554474,
      "116": 0.030900489538908005,
      "135": 0.03051581047475338,
      "4": 0.03028428740799427,
      "75": 0.030085362493991852,
      "31": 0.02958923578262329,
      "164": 0.02946683019399643,
      "136": 0.0276616383343935,
      "390": 0.026049450039863586,
      "494": 0.02575572393834591,
      "22": 0.02575531229376793,
      "398": 0.025584373623132706,
      "152": 0.02538244053721428
    },
    "trial_2_ae": {
      "87": 0.2718453109264374,
      "123": 0.22823187708854675,
      "68": 0.21703080832958221,
      "49": 0.20087939500808716,
      "177": 0.19001232087612152,
      "20": 0.15759731829166412,
      "173": 0.14548709988594055,
      "17": 0.14456668496131897,
      "9": 0.13350091874599457,
      "2": 0.13099779188632965,
      "37": 0.12950089573860168,
      "21": 0.12770411372184753,
      "189": 0.12567491829395294,
      "14": 0.11807842552661896,
      "77": 0.11389642208814621,
      "64": 0.11034133285284042,
      "46": 0.1103304997086525,
      "126": 0.10884558409452438,
      "228": 0.10099726915359497,
      "170": 0.09807759523391724,
      "114": 0.0967470332980156,
      "180": 0.09275546669960022,
      "76": 0.09180108457803726,
      "78": 0.09176316112279892,
      "67": 0.09068544209003448,
      "188": 0.08907242119312286,
      "101": 0.08794019371271133,
      "179": 0.08090319484472275,
      "350": 0.08047295361757278,
      "29": 0.0781339555978775,
      "194": 0.07758461683988571,
      "249": 0.0707063227891922,
      "144": 0.06981232762336731,
      "142": 0.06809403002262115,
      "61": 0.0676407665014267,
      "1": 0.06752006709575653,
      "27": 0.06512213498353958,
      "72": 0.0646979957818985,
      "35": 0.06454018503427505,
      "200": 0.06348308175802231,
      "30": 0.06330069899559021,
      "191": 0.05911820009350777,
      "96": 0.05865484103560448,
      "79": 0.05849825218319893,
      "269": 0.055773552507162094,
      "396": 0.0556010864675045,
      "147": 0.055376723408699036,
      "288": 0.054293207824230194,
      "82": 0.05287550389766693,
      "239": 0.05195028707385063,
      "261": 0.05123812332749367,
      "282": 0.05109192430973053,
      "5": 0.050557445734739304,
      "102": 0.050263166427612305,
      "243": 0.050208017230033875,
      "361": 0.049935147166252136,
      "193": 0.04978795349597931,
      "85": 0.04974762350320816,
      "441": 0.0497259758412838,
      "104": 0.04938671737909317,
      "253": 0.04879540577530861,
      "131": 0.048420269042253494,
      "151": 0.04732628911733627,
      "122": 0.04639523848891258,
      "211": 0.0462583564221859,
      "121": 0.045568738132715225,
      "38": 0.045035600662231445,
      "212": 0.04486526921391487,
      "86": 0.04134560003876686,
      "18": 0.041012924164533615,
      "69": 0.04052552208304405,
      "455": 0.040012259036302567,
      "130": 0.039924271404743195,
      "28": 0.03808409720659256,
      "186": 0.036559849977493286,
      "286": 0.0363871231675148,
      "355": 0.03584742918610573,
      "347": 0.03410690650343895,
      "133": 0.03388954699039459,
      "221": 0.0336710661649704,
      "100": 0.033637646585702896,
      "154": 0.03316114470362663,
      "234": 0.03257541358470917,
      "356": 0.0321459099650383,
      "466": 0.03201190382242203,
      "89": 0.03165391460061073,
      "276": 0.03159753978252411,
      "268": 0.031433410942554474,
      "116": 0.030900489538908005,
      "135": 0.03051581047475338,
      "4": 0.03028428740799427,
      "75": 0.030085362493991852,
      "31": 0.02958923578262329,
      "164": 0.02946683019399643,
      "136": 0.0276616383343935,
      "390": 0.026049450039863586,
      "494": 0.02575572393834591,
      "22": 0.02575531229376793,
      "398": 0.025584373623132706,
      "152": 0.02538244053721428
    }
  },
  "safety": {
    "trial_1_safety": 0.27364620566368103,
    "trial_2_safety": 0.27364620566368103
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47658824920654297
  }
}